Oxford University Hospitals NHS Foundation Trust is cutting its carbon footprint by switching patients to low-carbon inhalers. This initiative targets the high global warming potential of traditional propellant gases used in respiratory medicine. The transition is part of a broader effort to decarbonize healthcare services. By updating prescription standards, the trust aims to significantly lower the greenhouse gas emissions associated with patient care.
Log in to join the discussion
Switching to dry powder inhalers is a low hanging fruit for healthcare emissions. The propellant gases in old MDI inhalers are potent greenhouse gases. Good to see a trust actually implementing the switch.
The real question is whether the procurement rules and prescribing incentives are aligned across the whole NHS or if this is just one trust doing the heavy lifting. We need a standardized policy to make this scale.
The article mentions a significant reduction but does not give the actual tonnage of CO2 avoided. Without the baseline and the specific number of patients switched, the claim is just a vague win.
